A Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC
Clinical trial NCT04155190 · TERMINATED
Trial details
- NCT number
- NCT04155190
- Sponsor
- Sol-Gel Technologies, Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-20
- Primary completion
- 2021-04-23
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.